Skip to main content
Download PDF

Metabolic indexes of obesity in patients with common mental disorders in stable stage

BMC Psychiatry volume 22, Article number: 91 (2022) Cite this article

Abstract

Background

Obesity is a serious worldwide public health problem, especially for people with mental disorders.

Aim

To explore the related factors of obesity by analyzing the metabolic indexes of patients with common mental disorders in stable stage.

Methods

Five hundred seventy-six subjects with major depressive disorder (MDD), bipolar disorder (BD) or schizophrenia (SCZ) were included, who received fixed drug dose and routine drug treatment for 2 years or more. Their venous blood was collected, and the blood metabolic indexes were analyzed.

Results

BD and SCZ are more prone to obesity than MDD. Multiple linear regression analysis showed that the value of BMI increased with the increase of age(B = 0.084, p < 0.001), TG(B = 0.355, p = 0.024), LDL(B = 0.697, p < 0.001), LDH(B = 0.011, p = 0.002), SCr(B = 0.051, p < 0.001), UA(B = 0.014, p < 0.001), HbA1c(B = 0.702, p = 0.004) and hsCRP(B = 0.101, p < 0.001). And It decreased with the increase of HDL(B = -1.493, p < 0.001).

Discussion

People with mental disorders should regularly check blood indicators and strengthen weight management to reduce the risk of obesity and promote their health.

Peer Review reports

Introduction

Obesity is a serious worldwide public health problem. It was found that the number of obese people in China currently exceeds 85 million through continuous surveys in rural and urban areas across the country [1]. According to Chinese standards, about 50% of adults and 20% of children are overweight or obese [2].

Previous studies have shown that there was no significant difference in the incidence of obesity in the first-episode untreated major depressive disorder (MDD) [3], bipolar disorder (BD) [4] and schizophrenia (SCZ)) [5] compared with healthy controls. However, after using psychotropic drugs for a period of time, the weight of patients would increase in varying degrees, even to the extent of obesity [6].

The rationale for examining metabolic factor is underdeveloped and the connection between the psychiatric disorders and obesity and metabolic factors is poorly described. Some studies have shown that age, education, smoking, drinking and other living habits are related to obesity [7]. In terms of blood metabolic indexes, total cholesterol [8], low density lipoprotein [9], uric acid [10] and glycosylated hemoglobin [11] are also related to obesity, too. However, there are few studies on the analysis of multiple indicators, and the results are inconsistent.

Our study collected blood from patients with common mental disorders, no smoking and drinking habits. In order to find the related influencing factors of obesity and provide basis for clinical intervention.

Methods

Participants

Outpatients with MDD, BD and SCZ were included in this study, who met the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) from May 2015 to October 2020 in the Third People's hospital of Foshan, Guangdong, China(Foshan is located in the northern part of the Pearl River, 20 km (12 miles) from Guangzhou, Guangdong Province). Their age was ≥ 18 years old, and they were required to maintain a fixed drug dose pattern for 2 years or more (in the stable period) before blood testing.

Exclusion criteria: ①Comorbidity and other mental disorders, including mental retardation or other cognitive impairment; ②Patients with severe and unstable physical diseases, including severe liver and kidney function damage, cardiac insufficiency, etc.; ③Smoking habits(≥ 1 cigarette per day) or drinking habits(≥ 1 unit alcohol per week); 1 unit alcohol = 480 ~ 600 ml of beer = 350 ml of low alcohol liquor or red wine, yellow wine = 50 ml of high spirits (that is 40 degrees or more); ④Those who cann’t cooperate with venous blood drawing, such as phobia, etc.

Assessments

For the subjects who met the above conditions and were willing to participate in the study, after signed the informed consent, collected the names, gender and age of the subjects through interviews. The height and weight of the subjects were measured with Automatic Measuring Stadiometer BSM370 (smitechasia.com) and the BMI (kg / m2) of each subject was calculated.

Whether the subject was overweight or obese was defined, according to the diagnostic criteria of overweight and obesity proposed by the China Obesity working group (24 kg/m2 ≤ BMI < 28 kg/m2 as overweight, BMI ≥ 28 kg/m2 as obesity and BMI < 24 kg/m2 as non obesity) [12].

Before drawing the venous blood of the subjects, they were required to be fasting for more than 8 h, and the nurses were required to complete the blood drawing of them from 7:30 to 10:00 in the morning. The night before blood drawing, the subjects need to maintain a normal diet, follow the previous work and rest, do not exercise violently, do not drink alcohol or coffee after dinner. Total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creative kinase (CK), creative kinase isoenzyme (CK-MB), urea, serum creatinine (SCr), uric acid (UA), alanine aminotransferase (ALT), fast blood glucose (FBG), glycosylated hemoglobin (HbA1c), high sensitivity C-reactive protein (HsCRP) and homocysteine (Hcy) were recorded in the clinical data sheet of the subjects.

Data analyses

Statistical Product and Service Solutions 21 software (SPSS 21, https://www.ibm.com/analytics/spss-statistics-software) was used to analyze the data. Chi square test was used to compare the differences of general demographic and blood metabolic indexes among MDD, BD and SCZ. The relationship between BMI and variable indexes was analyzed by Pearson correlation. Multiple linear regression was used to analyze the effects of blood index components on BMI.

Result

Comparison of demographic characteristics and metabolic indexes

A total of 576 subjects were included in this study, including MDD (n = 242), BD (n = 124) and SCZ (n = 210), while 24 subjects were excluded because of refusing to participate in the study, eating breakfast before blood drawing, or refusing to take medicine. There were no significant differences in age, sex, height, BMI, TC, TG, HDL, LDL, AST, CK, CK-MB, SCr, FBG, HbA1c and HsCRP among MDD, BD and SCZ (p > 0.05); And there were significant differences in body weight, BMI, LDH, urea, UA, ALT(U/L) and Hcy (p < 0.05). The incidence of obesity in MDD, BD and SCZ was 9.92%, 17.74% and 19.91% respectively. Overweight was 24.79%, 34.68% and 34.12% (Table 1).

Table 1 Comparison of demographic characteristics and metabolic indexes
Full size table

Correlation between BMI and various indexes

The results of Person correlation analysis showed that BMI was positively correlated with age, TC, TG, LDL, AST, LDH, SCr, UA, alt, FBG, HbA1c and hsCRP, and negatively correlated with HDL (Table 2).

Table 2 Correlation between BMI and various indexes
Full size table

Multiple linear regression analysis of influencing factors of BMI

Taking BMI as dependent variable (Y) and age, TC, TG, HDL, LDL, AST, LDH, SCr, UA, Alt, FBG, HbA1c and HsCRP as independent variables (X), gender as covariate, a stepwise multiple linear regression model (F = 44.792, p < 0.001) was established for analysis. Finally, the elements entering the model were age, TG, HDL, LDL, LDH, SCr, UA, HbA1c and HsCRP (Table 3).

Table 3 Multiple linear regression analysis of influencing factors of BMI
Full size table

Discussion

Our study included MDD, BD and SCZ patients who had treated with fixed doses of drugs for 2 years or more, and excluded smoking and drinking habits. The metabolism indexes were included in the analysis to explore the influencing factors of obesity, so as to provide reference for further clinical intervention.

The subjects of our study came from southern cities in China. According to a large-scale national epidemiological survey, the results show that the prevalence of obesity in urban areas in southern China was 2.8–7.2% from 2010 to 2018 [1]. Our results showed that the incidence of obesity in MDD, BD or SCZ is higher than the above data. This indicated that patients who regularly use psychotropic drugs for a long time have a higher incidence of obesity. What’s more, the possibility of obesity and overweight in BD and SCZ was higher than MDD, which is similar to the results of previous studie [13]. Clinically, the drug combination in BD and SCZ is more often, and the weight gain caused by mood stabilizer and antipsychotics is also difficult to avoid. Therefore, doctors need to pay more attention to the weight management in routine treatment [14].

The results of this study suggested that age, TG, LDL, LDH, SCr, UA, HbA1c and HsCRP were positively correlated with BMI, HDL was negatively correlated with BMI, which finally entered the multiple linear regression model. We found that age was a risk factor for obesity. With the increase of age, the risk of obesity will also increase. However, a previous study suggested that male's BMI decreases with age, while female's BMI increases with age [15]. This partially overlapped with our findings, which might be related to regional differences when we included subjects.

We also found that BMI was positively correlated with TG and LDL. Their effects on obesity have been unanimously recognized. It is generally believed that their increase is strongly related to the occurrence of obesity [16]. Therefore, in patients with stable mental disorders, regular monitoring of TG and LDL value is of great significance to prevent obesity.

LDH is an important enzyme in the process of glycolysis. And it is an important indicator of liver function together with ALT. Some studies had found that overweight and obesity were related to the increase of biochemical indexes of liver injury (LDH and ALT), which were involved in the occurrence of obesity [17].

Serum creatinine is the product of human muscle metabolism. It is closely related to the total amount of muscle in the body and is not easily affected by diet. In muscle, creatine slowly forms creatinine mainly through irreversible non enzymatic dehydration reaction, which is then released into the blood, filtered through glomerulus, and almost all of it is discharged with urine. Clinically, the detection of serum creatinine is an important index of renal function. The increase of serum creatinine means the damage of renal function. When studying longitudinal studies on diabetes, researchers found that the decrease of renal function was positively correlated with obesity [18]. In addition, uric acid is also metabolized through the kidney. Some people suggested that its increase was related to the increase of body weight and blood pressure [19]. Higher UA is significantly associated with increased risk of diabetes, especially among overweight people [20]. HbA1c reflects the average blood glucose level of the body for three months, and it is also an important indicator of diabetes diagnosis. Obesity often occurs in the early stages of diabetes, so HbA1c is easily understood by us as a risk factor for obesity. For patients with stable mental disorders, regular monitoring of SCr, UA and HbA1c can prevent the occurrence of complications.

HsCRP is an acute phase protein synthesized by hepatocytes during inflammatory stimulation such as tissue injury. As a member of inflammatory factors, it participates in the disease process of MDD, BD and SCZ [21]. Cho s et al. believed that it is associated with obesity at the same time [22]. Therefore, our study verifies the previous research and achieves good consistency.

All in all, it is not surprising that the above indicators are abnormal, but these indicators are related to the patient's liver function, kidney function, cardiac function and various lipid metabolism in the body, which is related to the in vivo action pathway of various psychotropic drugs. Therefore, in patients with long-term medication, testing these indicators will help to timely understand the physical health status, make corresponding intervention measures in advance, or adjust drug use to avoid obesity and other health problems.

Unfortunately, our study ruled out the patients with smoking and drinking habits, which might cause partial data deviation. Although many previous studies suggest that there is no difference in the incidence of obesity between the first-episode untreated patients with mental disorders and healthy controls, the causal relationship between obesity and various indicators still needs to be further explored. Therefore, we still need to be cautious in the promotion of follow-up conclusions.

In conclusion, patients with stable mental disorders should strengthen the monitoring of relevant blood indicators and weight management, so as to reduce the risk of obesity and promote their health.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available due to confidentiality but are available from the corresponding author on reasonable request.

References

  1. Wang L, Zhou B, Zhao Z, Yang L, Zhang M, Jiang Y, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18. Lancet (London, England). 2021;398(10294):53–63.

    Article  Google Scholar 

  2. Wang Y, Zhao L, Gao L, Pan A, Xue H. Health policy and public health implications of obesity in China. Lancet Diabetes Endocrinol. 2021;9(7):446–61.

    Article  Google Scholar 

  3. Si T, Yang K, Lang X, Dong X, Wang N, Zhang X, et al. Prevalence and risk factors of overweight and obesity in Chinese patients with first-episode drug-naïve major depressive disorder. J Affect Disord. 2021;286:351–9.

    Article  Google Scholar 

  4. Strassnig M, Kotov R, Cornaccio D, Fochtmann L, Harvey PD, Bromet EJ. Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis. Bipolar disorders. 2017;19(5):336–43.

    Article  Google Scholar 

  5. Tian Y, Wang D, Wei G, Wang J, Zhou H, Xu H, et al. Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls. Psychopharmacology. 2020;238(3):745–53 (prepublish).

    Article  Google Scholar 

  6. Correll C, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World psychiatry : official journal of the World Psychiatric Association (WPA). 2015;14(2):119–36.

    Article  Google Scholar 

  7. Zhang L, Wang Z, Wang X, Chen Z, Shao L, Tian Y, et al. Prevalence of overweight and obesity in China: Results from a cross-sectional study of 441 thousand adults, 2012–2015. Obes Res Clin Pract. 2020;14(2):119–26.

    Article  Google Scholar 

  8. Yki-Järvinen H, Luukkonen P, Hodson L, Moore J. Dietary carbohydrates and fats in nonalcoholic fatty liver disease. Nature reviews Gastroenterology & hepatology. 2021;18(11):770–86.

    Article  Google Scholar 

  9. Tonouchi R, Okada T, Abe Y, Kazama M, Kuromori Y, Yoshino Y, et al. Subclass distribution of low-density lipoprotein triglyceride and the clustering of metabolic syndrome components in Japanese children. Pediatrics international : official journal of the Japan Pediatric Society. 2021;63(6):664–70.

    Article  CAS  Google Scholar 

  10. Zheng R, Chen C, Yang T, Chen Q, Lu R, Mao Y. Serum Uric Acid Levels and the Risk of Obesity: a Longitudinal Population-Based Epidemiological Study. Clin Lab. 2017;63(10):1581–7.

    CAS  PubMed  Google Scholar 

  11. McDiarmid S, Harvie M, Johnson R, Vyas A, Aglan A, Moran J, Ruane H, Hulme A, Sellers K, Issa BG. Manchester Intermittent versus Daily Diet App Study (MIDDAS): A pilot randomized controlled trial in patients with type 2 diabetes. Diabetes Obes Metab. 2021. https://doi.org/10.1111/dom.14592.

  12. Zeng Q, Li N, Pan X, Chen L, Pan A. Clinical management and treatment of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):393–405.

    Article  Google Scholar 

  13. Strassnig M, Kotov R, Cornaccio D, Fochtmann L, Harvey P, Bromet E. Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis. Bipolar Disord. 2017;19(5):336–43.

    Article  Google Scholar 

  14. Penninx B, Lange S. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1):63–73.

    Article  Google Scholar 

  15. Park H, Hong Y, Cho Y, Lee J, Yun J, Kwon H, et al. Trends and Cut-Point Changes in Obesity Parameters by Age Groups Considering Metabolic Syndrome. Journal of Korean medical science. 2018;33(7):e47.

    Article  Google Scholar 

  16. Zhang Y, Yang J, Ye J, Guo Q, Wang W, Sun Y, et al. Separate and combined associations of physical activity and obesity with lipid-related indices in non-diabetic and diabetic patients. Lipids Health Dis. 2019;18(1):49.

    Article  Google Scholar 

  17. Johansen M, Gade J, Stender S, Frithioff-Bøjsøe C, Lund M, Chabanova E, et al. The Effect of Overweight and Obesity on Liver Biochemical Markers in Children and Adolescents. The Journal of clinical endocrinology and metabolism. 2020;105(2):dgz010.

    Article  Google Scholar 

  18. Kim B, Choi D, Jung C, Mok J, Kim C. Associations between obesity, weight change and decreased renal function in Korean type 2 diabetic patients: a longitudinal follow-up study. BMC Endocr Disord. 2021;21(1):188.

    Article  Google Scholar 

  19. Li Q, Li R, Zhang S, Zhang Y, Liu M, Song Y, Liu C, Liu L, Wang X, Wang B, Xu X, Qin X.. Relation of BMI and waist circumference with the risk of new-onset hyperuricemia in hypertensive patients. QJM. 2021 Jan 24:hcaa346.https://doi.org/10.1093/qjmed/hcaa346.

  20. Li F, Duan J, Yang Y, Yan G, Chen Z, Wang J, et al. Distinct uric acid trajectories are associated with incident diabetes in an overweight Chinese population. Diabetes & metabolism. 2021;47(2):101175.

    Article  CAS  Google Scholar 

  21. Goldsmith D, Rapaport M, Miller B. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696–709.

    Article  CAS  Google Scholar 

  22. Cho S, Lim J, Lee J, Lee J, Jeong H, Lee M, et al. Association between high-sensitivity C-reactive protein levels and depression: Moderation by age, sex, obesity, and aerobic physical activity. J Affect Disord. 2021;291:375–83.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

This research was supported by the project of Foshan Science and Technology Bureau (2020001005608, 2020001005782) and the HighLevel Hospital Development Program for Foshan “Climbing” Project (DF-04–02-002).

Author information

Authors and Affiliations

  1. Department of Psychiatry, The Third People’s Hospital of Foshan, Guangdong, People’s Republic of China

    Xiaoling Li, Yukang Tan, Yang Yu, Chaohua Tang, Guohong Xu, Xinglian Zhang, Hairong Liao, Xiancong Mai, Wensheng Chen, Caixia Xu, Guojun Xie & Jiaquan Liang

  2. Center On Translational Neuroscience, Minzu University of China, Beijing, People’s Republic of China

    Xiaojie Shi, Xin Luo & Jiaquan Liang

Authors
  1. Xiaoling Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaojie Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukang Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chaohua Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guohong Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xinglian Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hairong Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiancong Mai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wensheng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xin Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Caixia Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Guojun Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jiaquan Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Jiaquan Liang and Xiaoling Li both made substantial contributions to the conception or design of the work as well as the acquisition, analysis, or interpretation of data; they both aided in drafting the work, gave final approval of the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The author(s) read and approved the final manuscript.

Corresponding authors

Correspondence to Guojun Xie or Jiaquan Liang.

Ethics declarations

Ethics approval and consent to participate

We obtained written informed consent from all patients. This study was approved by the ethics committee of the Third People's Hospital of Foshan, China and the experiments were conducted following the declaration of Helsinki.

Consent for publication

Not applicable

Competing interests

The authors have no potential or actual conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Shi, X., Tan, Y. et al. Metabolic indexes of obesity in patients with common mental disorders in stable stage. BMC Psychiatry 22, 91 (2022). https://doi.org/10.1186/s12888-022-03752-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-022-03752-2

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us